ym 529 has been researched along with Ewing Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kubo, T; Matsuo, T; Ochi, M; Sakai, A; Shimose, S | 1 |
1 other study(ies) available for ym 529 and Ewing Sarcoma
Article | Year |
---|---|
Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Doxorubicin; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; Imidazoles; Indicators and Reagents; Mice; Mice, Nude; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Protein Prenylation; Sarcoma, Ewing; Signal Transduction; Xenograft Model Antitumor Assays | 2008 |